TY - JOUR T1 - COVID-19 and Heart: From Clinical Features to Pharmacological Implications. AU - Russo,Vincenzo, AU - Bottino,Roberta, AU - Carbone,Andreina, AU - Rago,Anna, AU - Papa,Andrea Antonio, AU - Golino,Paolo, AU - Nigro,Gerardo, Y1 - 2020/06/22/ PY - 2020/04/29/received PY - 2020/06/06/revised PY - 2020/06/10/accepted PY - 2020/6/26/entrez PY - 2020/6/26/pubmed PY - 2020/6/26/medline KW - angiotensin-converting enzyme inhibitor KW - arrhythmias KW - cardiac biomarkers KW - cardiovascular diseases KW - coronavirus disease 2019 (COVID-19) KW - myocardial injury JF - Journal of clinical medicine JO - J Clin Med VL - 9 IS - 6 N2 - A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clinical features at hospital admission and prognosis for disease severity. The aim of our review is to describe the cardiological features of COVID-19 patients at admission, the acute cardiac presentation, the clinical outcome for patients with underlying CVD and the pharmacological implications for disease management. SN - 2077-0383 UR - https://www.unboundmedicine.com/medline/citation/32580344/COVID_19_and_Heart:_From_Clinical_Features_to_Pharmacological_Implications_ DB - PRIME DP - Unbound Medicine ER -